 Rashikh Choudhury
Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 12 | 2026 | 293 | 4.890 |
Why?
| | Kidney Transplantation | 11 | 2026 | 712 | 3.240 |
Why?
| | Gastrectomy | 9 | 2026 | 166 | 3.100 |
Why?
| | Liver Transplantation | 19 | 2025 | 826 | 2.760 |
Why?
| | Gastric Bypass | 6 | 2023 | 126 | 2.210 |
Why?
| | Decision Support Techniques | 12 | 2026 | 477 | 1.970 |
Why?
| | Kidney Failure, Chronic | 5 | 2025 | 599 | 1.880 |
Why?
| | Tissue and Organ Procurement | 7 | 2026 | 343 | 1.570 |
Why?
| | Tissue Donors | 5 | 2026 | 420 | 1.300 |
Why?
| | Bariatric Surgery | 5 | 2026 | 252 | 1.300 |
Why?
| | Markov Chains | 7 | 2026 | 132 | 1.280 |
Why?
| | Death | 3 | 2022 | 132 | 1.170 |
Why?
| | Weight Loss | 9 | 2026 | 858 | 1.060 |
Why?
| | Health Services Accessibility | 3 | 2025 | 1101 | 1.060 |
Why?
| | Renal Veins | 1 | 2025 | 18 | 0.910 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2025 | 8 | 0.910 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.900 |
Why?
| | Tissue Plasminogen Activator | 3 | 2020 | 248 | 0.800 |
Why?
| | Living Donors | 5 | 2022 | 282 | 0.790 |
Why?
| | Graft Survival | 9 | 2026 | 518 | 0.720 |
Why?
| | Digestive System Surgical Procedures | 2 | 2020 | 112 | 0.670 |
Why?
| | Stents | 1 | 2025 | 564 | 0.660 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 265 | 0.650 |
Why?
| | Body Mass Index | 7 | 2026 | 2445 | 0.650 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.620 |
Why?
| | Organ Transplantation | 2 | 2021 | 251 | 0.600 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2026 | 668 | 0.590 |
Why?
| | Salvage Therapy | 1 | 2020 | 165 | 0.580 |
Why?
| | Obesity | 7 | 2025 | 3116 | 0.560 |
Why?
| | Robotic Surgical Procedures | 3 | 2026 | 185 | 0.480 |
Why?
| | Heart Transplantation | 2 | 2023 | 680 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.430 |
Why?
| | Coronavirus Infections | 1 | 2020 | 383 | 0.430 |
Why?
| | Life Expectancy | 1 | 2014 | 73 | 0.410 |
Why?
| | Humans | 45 | 2026 | 145475 | 0.390 |
Why?
| | Middle Aged | 24 | 2026 | 36215 | 0.390 |
Why?
| | Waiting Lists | 5 | 2022 | 266 | 0.360 |
Why?
| | Treatment Outcome | 12 | 2026 | 11772 | 0.350 |
Why?
| | Heart Failure | 2 | 2023 | 2326 | 0.320 |
Why?
| | Donor Selection | 2 | 2021 | 79 | 0.310 |
Why?
| | Survival Rate | 6 | 2023 | 2090 | 0.300 |
Why?
| | Blood Coagulation Disorders | 2 | 2022 | 198 | 0.290 |
Why?
| | Brain Death | 2 | 2026 | 60 | 0.280 |
Why?
| | Exercise Therapy | 1 | 2013 | 475 | 0.280 |
Why?
| | United States | 11 | 2023 | 16098 | 0.270 |
Why?
| | End Stage Liver Disease | 3 | 2023 | 95 | 0.240 |
Why?
| | Retrospective Studies | 16 | 2026 | 17291 | 0.230 |
Why?
| | Male | 21 | 2026 | 72843 | 0.230 |
Why?
| | Thrombelastography | 3 | 2022 | 192 | 0.220 |
Why?
| | Female | 21 | 2026 | 78845 | 0.220 |
Why?
| | Transplantation, Autologous | 1 | 2025 | 300 | 0.210 |
Why?
| | Organ Preservation | 1 | 2025 | 125 | 0.210 |
Why?
| | Perfusion | 1 | 2025 | 251 | 0.200 |
Why?
| | Solanum tuberosum | 1 | 2022 | 8 | 0.180 |
Why?
| | Mesothelioma | 1 | 2022 | 51 | 0.180 |
Why?
| | Blood Coagulation | 2 | 2022 | 274 | 0.180 |
Why?
| | Peritoneal Neoplasms | 1 | 2022 | 104 | 0.170 |
Why?
| | Seeds | 1 | 2022 | 69 | 0.170 |
Why?
| | Hyperthermia, Induced | 1 | 2022 | 120 | 0.170 |
Why?
| | Parents | 2 | 2020 | 1403 | 0.170 |
Why?
| | Fibrinolysis | 2 | 2020 | 164 | 0.160 |
Why?
| | Comprehension | 1 | 2022 | 186 | 0.160 |
Why?
| | Pilonidal Sinus | 1 | 2020 | 4 | 0.160 |
Why?
| | Reperfusion | 1 | 2020 | 54 | 0.160 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2020 | 41 | 0.160 |
Why?
| | Biliary Atresia | 1 | 2022 | 158 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 52 | 0.150 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 153 | 0.150 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 102 | 0.150 |
Why?
| | Clinical Decision-Making | 2 | 2020 | 363 | 0.150 |
Why?
| | Hepatitis C | 1 | 2022 | 256 | 0.140 |
Why?
| | Adult | 15 | 2026 | 40777 | 0.140 |
Why?
| | Postoperative Period | 2 | 2020 | 351 | 0.140 |
Why?
| | Wound Healing | 1 | 2020 | 355 | 0.130 |
Why?
| | Resuscitation | 1 | 2020 | 310 | 0.130 |
Why?
| | Matched-Pair Analysis | 1 | 2017 | 37 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.130 |
Why?
| | Drug Overdose | 1 | 2021 | 374 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 568 | 0.120 |
Why?
| | Graft Rejection | 1 | 2020 | 521 | 0.120 |
Why?
| | Postoperative Complications | 3 | 2020 | 2970 | 0.120 |
Why?
| | Allografts | 1 | 2017 | 152 | 0.120 |
Why?
| | Kidney | 2 | 2022 | 1497 | 0.120 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1547 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 527 | 0.110 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2015 | 4 | 0.110 |
Why?
| | Databases, Factual | 2 | 2021 | 1490 | 0.110 |
Why?
| | Time Factors | 4 | 2021 | 7123 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1707 | 0.110 |
Why?
| | Peritoneal Cavity | 1 | 2014 | 30 | 0.110 |
Why?
| | Chemotherapy, Cancer, Regional Perfusion | 1 | 2014 | 30 | 0.110 |
Why?
| | Delayed Graft Function | 2 | 2026 | 46 | 0.110 |
Why?
| | Infant, Newborn | 3 | 2021 | 6447 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 969 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5423 | 0.100 |
Why?
| | Risk Factors | 5 | 2024 | 10885 | 0.100 |
Why?
| | Registries | 2 | 2020 | 2406 | 0.100 |
Why?
| | Prognosis | 3 | 2024 | 4316 | 0.100 |
Why?
| | Critical Illness | 1 | 2020 | 900 | 0.100 |
Why?
| | Gastroplasty | 1 | 2013 | 32 | 0.100 |
Why?
| | Morbidity | 1 | 2014 | 322 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1327 | 0.100 |
Why?
| | Diet Therapy | 1 | 2013 | 36 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 602 | 0.100 |
Why?
| | Microbiota | 1 | 2020 | 730 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 767 | 0.090 |
Why?
| | Knee Prosthesis | 1 | 2012 | 28 | 0.090 |
Why?
| | Weight Reduction Programs | 1 | 2013 | 140 | 0.090 |
Why?
| | Prosthesis-Related Infections | 1 | 2012 | 98 | 0.080 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 287 | 0.080 |
Why?
| | Healthcare Disparities | 1 | 2018 | 735 | 0.080 |
Why?
| | Operative Time | 2 | 2026 | 181 | 0.080 |
Why?
| | Young Adult | 4 | 2023 | 14219 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1963 | 0.080 |
Why?
| | Endocrine System | 1 | 2009 | 22 | 0.080 |
Why?
| | Aged | 8 | 2026 | 26153 | 0.080 |
Why?
| | Adipogenesis | 1 | 2009 | 56 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 181 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1371 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2009 | 129 | 0.070 |
Why?
| | Adipocytes | 1 | 2009 | 223 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 870 | 0.070 |
Why?
| | Propensity Score | 2 | 2023 | 377 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 718 | 0.060 |
Why?
| | Child | 6 | 2022 | 22707 | 0.060 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 866 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2022 | 1266 | 0.060 |
Why?
| | Length of Stay | 2 | 2026 | 1349 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 2121 | 0.050 |
Why?
| | Prospective Studies | 3 | 2020 | 8057 | 0.050 |
Why?
| | Liver | 2 | 2022 | 1896 | 0.050 |
Why?
| | Ecuador | 1 | 2022 | 14 | 0.050 |
Why?
| | Risk Assessment | 2 | 2022 | 3747 | 0.040 |
Why?
| | Plant Diseases | 1 | 2022 | 44 | 0.040 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2022 | 69 | 0.040 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2022 | 43 | 0.040 |
Why?
| | Kenya | 1 | 2022 | 129 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 278 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 191 | 0.040 |
Why?
| | Incidence | 2 | 2020 | 2923 | 0.040 |
Why?
| | Austria | 1 | 2020 | 8 | 0.040 |
Why?
| | Surgeons | 1 | 2025 | 340 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2020 | 69 | 0.040 |
Why?
| | Switzerland | 1 | 2020 | 46 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 55 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 92 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 105 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 420 | 0.040 |
Why?
| | Hepacivirus | 1 | 2022 | 242 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2020 | 156 | 0.040 |
Why?
| | Cause of Death | 1 | 2021 | 470 | 0.040 |
Why?
| | Surgical Flaps | 1 | 2020 | 142 | 0.040 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 418 | 0.040 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 85 | 0.040 |
Why?
| | Preoperative Period | 1 | 2019 | 149 | 0.030 |
Why?
| | Sex Factors | 1 | 2024 | 2105 | 0.030 |
Why?
| | Cohort Studies | 2 | 2021 | 6013 | 0.030 |
Why?
| | Eligibility Determination | 1 | 2018 | 72 | 0.030 |
Why?
| | Infant | 2 | 2022 | 10077 | 0.030 |
Why?
| | Fetus | 1 | 2020 | 804 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 769 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3623 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11853 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2019 | 409 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 133 | 0.030 |
Why?
| | Age Factors | 1 | 2021 | 3342 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 732 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2014 | 423 | 0.020 |
Why?
| | Remission Induction | 1 | 2012 | 307 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2014 | 8333 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2014 | 1471 | 0.020 |
Why?
| | Estrogens, Non-Steroidal | 1 | 2009 | 10 | 0.020 |
Why?
| | Endrin | 1 | 2009 | 13 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1374 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2009 | 36 | 0.020 |
Why?
| | Phthalic Acids | 1 | 2009 | 42 | 0.020 |
Why?
| | Luciferases | 1 | 2009 | 153 | 0.020 |
Why?
| | Benzhydryl Compounds | 1 | 2009 | 81 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 671 | 0.020 |
Why?
| | Patient Selection | 1 | 2013 | 738 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 633 | 0.020 |
Why?
| | Phenols | 1 | 2009 | 106 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 277 | 0.020 |
Why?
| | Prednisone | 1 | 2009 | 224 | 0.020 |
Why?
| | Environment | 1 | 2009 | 293 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 239 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6066 | 0.020 |
Why?
| | Genetic Testing | 1 | 2009 | 480 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 588 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 529 | 0.010 |
Why?
| | Diet | 1 | 2013 | 1277 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 531 | 0.010 |
Why?
| | Stem Cells | 1 | 2009 | 628 | 0.010 |
Why?
| | Adolescent | 1 | 2023 | 22530 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 2046 | 0.010 |
Why?
| | Exercise | 1 | 2013 | 2198 | 0.010 |
Why?
| | Mice | 1 | 2009 | 18329 | 0.010 |
Why?
| | Animals | 1 | 2009 | 38030 | 0.000 |
Why?
|
|
Choudhury's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|